BNP Paribas Call 25 MOR 20.12.202.../ DE000PN2G877 /
10/05/2024 18:14:16 | Diferencia- | Bid22:00:37 | Ask22:00:37 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
4.23EUR | - | - Volumen de oferta: - |
- Tamaño/ Volumen/ Formato de Ask: - |
MORPHOSYS AG O.N. | 25.00 - | 20/12/2024 | Call |
GlobeNewswire
9:30
XTCC partners with Circulariti to support sustainability and carbon neutrality in the end to end fa...
Newsfile Corp
9:06
me88 Launches me scoreAI: Revolutionizing Football Predictions for UEFA Euro Cup 2024
GlobeNewswire
9:00
insightsoftware to Strengthen xP&A and Write-Back Capabilities in Qlik With Fiplana Acquisition
GlobeNewswire
8:14
STMicroelectronics to build the world’s first fully integrated silicon carbide facility in Italy
GlobeNewswire
8:00
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
GlobeNewswire
7:30
Baosheng Media Group Holdings Limited Announces Filing of Current Report on Form 6-K with the SEC re...
GlobeNewswire
7:05
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GlobeNewswire
7:05
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página